Pascal and Francis Bibliographic Databases

Help

Search results

Your search

kw.\*:("PERHEXILINE")

Document Type [dt]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Language

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 307

  • Page / 13

Export

Selection :

  • and

NEUROPATHIE PERIPHERIQUE APRES ABSORPTION PROLONGEE DE MALEATE DE PERHEXILINE. DEUX CAS.BOURRAT C; VIALA JJ; GUASTALA JP et al.1975; NOUV. PRESSE MED.; FR.; DA. 1975; VOL. 4; NO 35; PP. 2528Article

Steady-state pharmacokinetics of the enantiomers of perhexiline in CYP2D6 poor and extensive metabolisers administered Rac-perhexilineDAVIES, Benjamin J; HERBERT, Megan K; COLLER, Janet K et al.British journal of clinical pharmacology. 2008, Vol 65, Num 3, pp 347-354, issn 0306-5251, 8 p.Article

Metabolic modulation in dilated cardiomyopathyTUUNANEN, Helena; KNUUTI, Juhani.Heart and metabolism. 2010, Num 49, pp 19-22, issn 1566-0338, 4 p.Article

Enantioselective assay for the determination of perhexiline enantiomers in human plasma by liquid chromatographyDAVIES, Benjamin J; HERBERT, Megan K; CULBEN, Julie A et al.Journal of chromatography. B. 2006, Vol 832, Num 1, pp 114-120, issn 1570-0232, 7 p.Article

Development of a regimen for rapid initiation of perhexiline therapy in acute coronary syndromesPHILPOTT, A; CHANDY, S; MORRIS, R et al.Internal medicine journal (Print). 2004, Vol 34, Num 6, pp 361-363, issn 1444-0903, 3 p.Article

Assessment of interlaboratory performance in the provision of perhexiline therapeutic drug monitoring services in AustraliaSALLUSTIO, B. C; MORRIS, R. G.Therapeutic drug monitoring. 1999, Vol 21, Num 4, pp 389-394, issn 0163-4356Conference Paper

Stereoselective pharmacokinetics of perhexilineGOULD, B. J; AMOAH, A. G. B; PARKE, D. V et al.Xenobiotica (London. Print). 1986, Vol 16, Num 5, pp 491-502, issn 0049-8254Article

LE PEXID (MALEATE DE PERHEXILINE). BILAN ACTUEL DES EFFETS INDESIRABLES.LERY N; BELHADJALI J; CLAUDEL S et al.1978; LYON MED.; FR.; DA. 1978; VOL. 239; NO 2; PP. 97-100Article

CLINICAL EVALUATION OF PERHEXILINE MALEATE IN THE TREATMENT OF PATIENTS WITH CHRONIC CORONARY INSUFFIENCY. = EVALUATION CLINIQUE DU MALEATE DE PERHEXILINE DANS LE TRAITEMENT DES MALADES AVEC UNE INSUFFISANCE CORONAIRE CHRONIQUEMASONI A; TOMASI AM; ORIANI GA et al.1975; AMER. HEART J.; U.S.A.; DA. 1975; VOL. 90; NO 2; PP. 145-152; BIBL. 1 P. 1/2Article

Beneficial clinical effects of perhexiline in patients with stable angina pectoris and acute coronary syndromes are associated with potentiation of platelet responsiveness to nitric oxideWILLOUGHBY, S. R; STEWART, S; CHIRKOV, Y. Y et al.European heart journal. 2002, Vol 23, Num 24, pp 1946-1954, issn 0195-668X, 9 p.Article

PERHEXILINE AND APHONIACOLEBUNDERS R; RANQUIN R.1981; ACTA OTO-RHINO-LARYNGOL. BELG.; ISSN 0001-6497; BEL; DA. 1981; VOL. 35; NO 2; PP. 215-216; ABS. FRE; BIBL. 3 REF.Article

LE MALEATE DE PERHEXILINE ET SES COMPLICATIONSPIET MICHEL.sd; FRA; REIMS: MILLE FEUILLES; DA. S.D.; 26; 110 P.; 30 CM; BIBL. 204 REF.; TH.: MED./REIMS/1979Thesis

ASPECTS ULTRASTRUCTURAUX DE LA NEUROPATHIE AU MALEATE DE PERHEXILINELEROY JP; VOLANT A; MABIN D et al.1981; ARCH. MED. OUEST; FRA; DA. 1981; VOL. 13; NO 5; PP. 219-225; 4 P.Article

SEPT NEUROPATHIES PERIPHERIQUES APRES TRAITEMENT PAR MALEATE DE PERHEXELINEBOUSSER MG; BOUCHE P; BROCHARD C et al.1976; NOUV. PRESSE MED.; FR.; DA. 1976; VOL. 5; NO 10; PP. 652-653; BIBL. 3 REF.Article

HYPOGLYCEMIE APRES MALEATE DE PERHEXILINE.ROGER P; NOGUE F; RAGNAUD JM et al.1975; NOUV. PRESS MED.; FR.; DA. 1975; VOL. 4; NO 37; PP. 2663; BIBL. 4 REF.Article

EFFETS SECONDAIRES DU MALEATE DE PERHEXILINE. IDENTIFICATION D'UNE POPULATION DOTEE D'UN RISQUE ACCRU D'INTOLERANCEGRAND A; SEPULCHRE P.1975; NOUV. PRESSE MED.; FR.; DA. 1975; VOL. 4; NO 10; PP. 744; BIBL. 2REF.Article

Correlation of CYP2D6 genotype with perhexiline phenotypic metabolizer statusBARCLAY, Murray L; SAWYERS, Steven M; BEGG, Evan J et al.Pharmacogenetics (London). 2003, Vol 13, Num 10, pp 627-632, issn 0960-314X, 6 p.Article

Clinical inhibition of CYP2D6-catalysed metabolism by the antianginal agent perhexilineDAVIES, Benjamin J. L; COLLER, Janet K; JAMES, Heather M et al.British journal of clinical pharmacology. 2004, Vol 57, Num 4, pp 456-463, issn 0306-5251, 8 p.Article

Concentration-time profile for perhexiline and hydroxyperhexiline in patients at steady stateJONES, Terry E; MORRIS, Raymond G; HOROWITZ, John D et al.British journal of clinical pharmacology. 2004, Vol 57, Num 3, pp 263-269, issn 0306-5251, 7 p.Article

Les nouvelles «polynévrites» médicamenteuses = New medicinal polynevritisSERRATRICE, G; CREMIEUX, G; DESNUELLE, C et al.Méditerranée médicale. 1986, Vol 14, Num 350, pp 19-22, issn 0302-9263Article

Perhexiline directly inhibits arterial myosin phosphorylation and stimulates cardiac myofibrillar ATPase activitySILVER, P. J.European journal of pharmacology. 1984, Vol 106, Num 1, pp 217-218, issn 0014-2999Article

Effects of perhexiline and nitroglycerin on vascular, neutrophil and platelet function in patients with stable angina pectorisLIBERTS, Elizabeth A; WILLOUGHBY, Scott R; KENNEDY, Jennifer A et al.European journal of pharmacology. 2007, Vol 560, Num 1, pp 49-55, issn 0014-2999, 7 p.Article

LIVER DAMAGE DUE TO PERHEXILINE MALEATEFORBES GB; RAKE MO; TAYLOR JE et al.1979; J. CLIN. PATHOL.; GBR; DA. 1979; VOL. 32; NO 12; PP. 1282-1285; BIBL. 8 REF.Article

POLYNEUROPATHY AFTER PERHEXILINE MALEATE THERAPYLHERMITTE F; FARDEAU M; CHEDRU F et al.1976; BRIT. MED. J.; G.B.; DA. 1976; NO 6020; PP. 1256; BIBL. 5 REF.Article

TRAITEMENT DE L'ANGOR CORONARIEN PAR LE MALEATE DE PERHEXILINE (A PROPOS DE 35 CAS)MARION J; LE GALL F; HAUTEVILLE D et al.1976; MEDITERRANEE MED.; FR.; DA. 1976; VOL. 4; NO 104; PP. 62-66; BIBL. 21 REF.Article

  • Page / 13